Total Holdings
125
Portfolio diversification across 125 positions
BBC
(NYSEARCA)Virtus LifeSci Biotech Clinical Trials ETF
$42.84-- (--)
Loading... - Market loading
BBC ETF Holdings: Virtus LifeSci Biotech Clinical Trials ETF
Complete portfolio holdings with allocation weights, sector breakdown, and geographic exposure for this Equity ETF. Analyze fund diversification and concentration.
Assets Under Management
$38.68M
Total fund assets
Expense Ratio
0.79%
Annual management fee
Fund Issuer
Virtus Investment Partners
NYSEARCA
Portfolio Allocations
Distribution breakdown by sector, asset type, and geographic region. Understand the fund's diversification strategy across markets and asset classes.
Loading chart...
Top 50 Holdings by Portfolio Weight
View ticker symbols, company names, asset types, and allocation percentages for each position
Scroll to see more
| # | Symbol | Name | Type | Weight |
|---|---|---|---|---|
| 1 |  | Erasca, Inc. | Stock | 3.50% |
| 2 |  | Tango Therapeutics, Inc. | Stock | 1.72% |
| 3 |  | Enliven Therapeutics, Inc. | Stock | 1.70% |
| 4 |  | Dianthus Therapeutics, Inc. | Stock | 1.52% |
| 5 |  | Alumis Inc. | Stock | 1.50% |
| 6 |  | Kodiak Sciences Inc. | Stock | 1.36% |
| 7 |  | Rezolute, Inc. | Stock | 1.32% |
| 8 |  | Corvus Pharmaceuticals, Inc. | Stock | 1.31% |
| 9 |  | Allogene Therapeutics, Inc. | Stock | 1.29% |
| 10 |  | Tyra Biosciences, Inc. | Stock | 1.28% |
| 11 |  | Oruka Therapeutics, Inc. | Stock | 1.27% |
| 12 |  | Definium Therapeutics, Inc. | Stock | 1.25% |
| 13 |  | CG Oncology, Inc. | Stock | 1.24% |
| 14 |  | Arcellx, Inc. | Stock | 1.21% |
| 15 |  | Tectonic Therapeutic, Inc. | Stock | 1.18% |
| 16 |  | Centessa Pharmaceuticals plc | Stock | 1.14% |
| 17 |  | Omeros Corporation | Stock | 1.12% |
| 18 |  | Intellia Therapeutics, Inc. | Stock | 1.12% |
| 19 |  | Spyre Therapeutics, Inc. | Stock | 1.10% |
| 20 |  | Edgewise Therapeutics, Inc. | Stock | 1.06% |
| 21 |  | Nektar Therapeutics | Stock | 1.05% |
| 22 |  | Precigen, Inc | Stock | 1.04% |
| 23 |  | Ventyx Biosciences Inc | Stock | 1.03% |
| 24 |  | Vir Biotechnology, Inc. | Stock | 1.02% |
| 25 |  | Relay Therapeutics, Inc. | Stock | 1.02% |
| 26 |  | Ironwood Pharmaceuticals, Inc | Stock | 1.01% |
| 27 |  | Vaxcyte, Inc. | Stock | 1.00% |
| 28 |  | Xenon Pharmaceuticals Inc. | Stock | 0.98% |
| 29 |  | uniQure N.V | Stock | 0.96% |
| 30 |  | AnaptysBio, Inc. | Stock | 0.96% |
| 31 |  | Belite Bio Inc ADR | Stock | 0.95% |
| 32 |  | Stoke Therapeutics, Inc | Stock | 0.92% |
| 33 |  | GH Research PLC | Stock | 0.91% |
| 34 |  | AbCellera Biologics Inc | Stock | 0.91% |
| 35 | | Mind Medicine (MindMed) Inc | Stock | 0.91% |
| 36 |  | Ideaya Biosciences Inc | Stock | 0.90% |
| 37 |  | Summit Therapeutics PLC | Stock | 0.89% |
| 38 |  | Rigel Pharmaceuticals Inc | Stock | 0.89% |
| 39 |  | Eyepoint Pharmaceuticals Inc | Stock | 0.89% |
| 40 |  | Recursion Pharmaceuticals, Inc. Class A Common Stock | Stock | 0.89% |
| 41 |  | COMPASS Pathways plc | Stock | 0.88% |
| 42 |  | Rocket Pharmaceuticals Inc | Stock | 0.88% |
| 43 |  | Beam Therapeutics Inc | Stock | 0.87% |
| 44 |  | Cytokinetics, Incorporated | Stock | 0.87% |
| 45 |  | Annexon Inc | Stock | 0.86% |
| 46 | A ADGI | Adagio Therapeutics Inc. Common Stock | Stock | 0.86% |
| 47 |  | REGENXBIO Inc | Stock | 0.86% |
| 48 |  | Apogee Therapeutics, Inc. Common Stock | Stock | 0.86% |
| 49 |  | Praxis Precision Medicines, Inc | Stock | 0.85% |
| 50 |  | Revolution Medicines, Inc | Stock | 0.85% |
Frequently Asked Questions About Virtus LifeSci Biotech Clinical Trials ETF Holdings
What are the top holdings in BBC?
Virtus LifeSci Biotech Clinical Trials ETF (BBC) holds 125 securities. View the complete list of top holdings sorted by portfolio weight, showing each security's ticker symbol, company name, asset type, and allocation percentage.
How concentrated is BBC's portfolio?
Portfolio concentration is measured by the weight of top holdings. A concentrated portfolio has fewer large positions with higher individual weights, while a diversified portfolio distributes holdings more evenly. Review BBC's holdings table to analyze concentration risk.
What is BBC's sector allocation?
The Sector Allocation chart shows how BBC distributes investments across different industries like Technology, Healthcare, Financials, and more. This sector exposure helps understand the fund's industry diversification strategy.
What countries does BBC invest in?
BBC's geographic exposure is shown in the Countries tab under Portfolio Allocations. This reveals the fund's international diversification and exposure to different regions and global markets.
How diversified is BBC ETF?
BBC's diversification can be assessed by reviewing its 125 holdings, sector allocation, and geographic exposure. A well-diversified ETF spreads investments across multiple securities, sectors, and regions to reduce concentration risk.